T-cell-rich HLA-haploidentical hematopoietic stem cell transplantation for relapsed/refractory pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia without posttransplant tyrosine kinase inhibitor therapy.
about
T-cell-rich HLA-haploidentical hematopoietic stem cell transplantation for relapsed/refractory pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia without posttransplant tyrosine kinase inhibitor therapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
T-cell-rich HLA-haploidentical ...... sine kinase inhibitor therapy.
@en
T-cell-rich HLA-haploidentical ...... sine kinase inhibitor therapy.
@nl
type
label
T-cell-rich HLA-haploidentical ...... sine kinase inhibitor therapy.
@en
T-cell-rich HLA-haploidentical ...... sine kinase inhibitor therapy.
@nl
prefLabel
T-cell-rich HLA-haploidentical ...... sine kinase inhibitor therapy.
@en
T-cell-rich HLA-haploidentical ...... sine kinase inhibitor therapy.
@nl
P2093
P2860
P356
P1476
T-cell-rich HLA-haploidentical ...... sine kinase inhibitor therapy.
@en
P2093
Atsushi Kikuta
Hideki Sano
Hitoshi Ohto
Kazuhiro Mochizuki
Mitsuko Akaihata
Shogo Kobayashi
P2860
P356
10.1002/PBC.26242
P577
2016-10-26T00:00:00Z